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Severe alterations of Cacium-Phospate metabolism are frequently associated with 
chronic kidney diseases. High levels of Phospate and low levels of vitamin D in 
subjects affected by chronic kidney disease are, in many cases, correlated with high 
risk of mortality. For this reason, administration of vitamin D represents the elective 
treatment. Nevertheless, vitamin D in itself induces a variety of side effects which 
in many cases can be avoided by the administration of vitamin D analogues. In this 
study we treated murine cardiomyocytes with different concentrations of vitamin D 
and paricalcitol (one of its analogues) for 48 hours. Cell morphology, cell prolifera-
tion, intracellular Calcium deposition, and cAMP level were investigated respectively 
by light microscopy, immunoenzymatic assay and Von Kossa staining. Results show 
that, in comparison to paricalcitol, vitamin D induces stronger side effects on car-
diomyocytes (such as cell proliferation, morphological changes, activation of signal 
transduction pathways). From our data emerges that paricalcitol induces less stressful 
effects on murine cardiomyocytes in comparison to what observed with vitamin D 
treatment. 
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